Why the study?
Does high dose atorvastatin (40 mg) improve endothelial function and carotid IMT compared to low dose atorvastatin (10 mg) in patients with variant angina?
Does high dose atorvastatin (40 mg) improve endothelial function and carotid IMT compared to low dose atorvastatin (10 mg) in patients with variant angina?
High-dose statin therapy did not provide significant additional benefit over low-dose statin therapy for improving endothelial function or carotid IMT in patients with variant angina.
Answers are grounded in this paper and cite their sources.
High-dose atorvastatin was not associated with greater FMD improvement than low-dose in variant angina; leaves open optimal dosing for endothelial function.
BACKGROUND: To compare the effects of low dose and high dose of statin treatment on endothelial function and carotid intima-media thickness (IMT) in patients with variant angina (VAP). METHODS: A total of 70 patients with VAP were divided into two groups; atorvastatin 10 mg treatment group (group I: n = 35, 54.2 ± 12.5 years) versus atorvastatin 40 mg treatment group (group II: n = 35, 52.6 ± 9.8 years). Flow mediated vasodilation (FMD) of the brachial artery and IMT of the carotid artery were compared between the groups after 6 months of statin treatment. RESULTS: The baseline FMD and carotid IMT were not different between the groups. After 6 months of statin therapy, FMD was significantly improved in both groups (7.7 ± 2.5% to 8.9 ± 2.2% in group I, p = 0.001, 7.9 ± 2.7% to 9.5 ± 2.8% in group II, p < 0.001), but the degree of FMD change and FMD at 6 month were not different between the groups. Carotid IMT were not changed in both groups after 6 months of statin therapy. CONCLUSION: The use of statin for 6 months significantly improved endothelial function in patients with VAP, but carotid IMT was not changed. The use of high dose statin did not show significant additional benefit as compared with the use of low dose statin. The present study suggested that statin therapy would be beneficial in the treatment of VAP.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: